Výsledky vyhledávání

Akademický článek

HIV testing week 2015: lowering barriers for HIV testing among high-risk groups in Amsterdam

Autor: M. Bartelsman, I. K. Joore, J. E. van Bergen, A. A. Hogewoning, F. R. Zuure, M. G. van Veen, On behalf of the HIV Transmission Elimination AMsterdam (H-TEAM) initiative

Publikováno v: BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-8 (2017)

Abstract Background Evaluation of the HIV Testing Week (HTW) 2015 in Amsterdam: the number of (positive) tested persons, characteristics and testing history of the tested population, the differences in attendance per location and the healthcare worke

Externí odkaz: https://doaj.org/article/5673b07b09cc437e9bcc2f1d54f61ff5

Zobrazit plný text záznamu

Akademický článek

Hepatitis E virus seroprevalence and determinants in various study populations in the Netherlands.

Autor: C J Alberts, M F Schim van der Loeff, S Sadik, F R Zuure, E J A J Beune, M Prins, M B Snijder, S M Bruisten

Publikováno v: PLoS ONE, Vol 13, Iss 12, p e0208522 (2018)

BackgroundThe epidemiology of hepatitis E virus (HEV) is not fully understood. In this study, we assessed putative risk factors for HEV seropositivity in various study populations in the Netherlands.MethodsData and samples from five different study p

Externí odkaz: https://doaj.org/article/c714579df6224094a3c883ceafabcb57

Zobrazit plný text záznamu

Plný text ve formátu HTML

The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms

Autor: S B, Willemse, D, Razavi-Shearer, F R, Zuure, I K, Veldhuijzen, E A, Croes, A J, van der Meer, D K, van Santen, J M, de Vree, R J, de Knegt, H L, Zaaijer, H W, Reesink, M, Prins, H, Razavi

Publikováno v: The Netherlands journal of medicine. 73(9)

Prevalence of hepatitis C virus (HCV) infection in the Netherlands is low (anti-HCV prevalence 0.22%). All-oral treatment with direct-acting antivirals (DAAs) is tolerable and effective but expensive. Our analysis projected the future HCV-related dis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::76b9a46c35fcb5b0503a8582bb409399
https://pubmed.ncbi.nlm.nih.gov/26582807

Zobrazit plný text záznamu

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2

Autor: A. Hatzakis, V. Chulanov, A. C. Gadano, C. Bergin, Z. Ben-Ari, J. Mossong, I. Schréter, O. Baatarkhuu, S. Acharya, I. Aho, A. C. Anand, M. I. Andersson, V. Arendt, P. Arkkila, K. Barclay, F. Bessone, S. Blach, N. Blokhina, C. R. Brunton, G. Choudhuri, L. Cisneros, E. A. Croes, Y. A. Dahgwahdorj, O. Dalgard, J. R. Daruich, N. R. Dashdorj, D. Davaadorj, R. J. de Knegt, M. de Vree, C. Estes, R. Flisiak, E. Gane, E. Gower, W. Halota, C. Henderson, P. Hoffmann, J. Hornell, D. Houlihan, S. Hrusovsky, P. Jarčuška, D. Kershenobich, K. Kostrzewska, P. Kristian, M. Leshno, Y. Lurie, A. Mahomed, N. Mamonova, N. Mendez-Sanchez, S. Norris, E. Nurmukhametova, P. Nymadawa, M. Oltman, J. Oyunbileg, Ts. Oyunsuren, G. Papatheodoridis, N. Pimenov, N. Prabdial-Sing, M. Prins, S. Radke, A. Rakhmanova, K. Razavi-Shearer, H. W. Reesink, E. Ridruejo, R. Safadi, O. Sagalova, J. F. Sanchez Avila, R. Sanduijav, V. Saraswat, C. Seguin-Devaux, S. R. Shah, I. Shestakova, A. Shevaldin, O. Shibolet, M. O. Silva, S. Sokolov, M. Sonderup, K. Souliotis, C. W. Spearman, T. Staub, C. Stedman, E. A. Strebkova, D. Struck, V. Sypsa, K. Tomasiewicz, L. Undram, A. J. van der Meer, D. van Santen, I. Veldhuijzen, F. G. Villamil, S. Willemse, E. Zuckerman, F. R. Zuure, P. Puri, H. Razavi

Publikováno v: Journal of viral hepatitis, 22(Suppl. 1), 26-45. Wiley-Blackwell
Journal of Viral Hepatitis, 22, 26-45. Wiley-Blackwell Publishing Ltd

Morbidity and mortality attributable to chronic hepatitis C virus (HCV) infection are increasing in many countries as the infected population ages. Models were developed for 15 countries to quantify and characterize the viremic population, as well as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82694ede3c156e3e345dc7846e7ecbad
https://pure.amc.nl/en/publications/the-present-and-future-disease-burden-of-hepatitis-c-virus-hcv-infections-with-todays-treatment-paradigm--volume-2(2a867973-4b39-400f-b2d8-b36552eb4d4b).html

Zobrazit plný text záznamu

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2

Autor: E, Gane, D, Kershenobich, C, Seguin-Devaux, P, Kristian, I, Aho, O, Dalgard, I, Shestakova, P, Nymadawa, S, Blach, S, Acharya, A C, Anand, M I, Andersson, V, Arendt, P, Arkkila, O, Baatarkhuu, K, Barclay, Z, Ben-Ari, C, Bergin, F, Bessone, N, Blokhina, C R, Brunton, G, Choudhuri, V, Chulanov, L, Cisneros, E A, Croes, Y A, Dahgwahdorj, J R, Daruich, N R, Dashdorj, D, Davaadorj, R J, de Knegt, M, de Vree, A C, Gadano, E, Gower, W, Halota, A, Hatzakis, C, Henderson, P, Hoffmann, J, Hornell, D, Houlihan, S, Hrusovsky, P, Jarčuška, K, Kostrzewska, M, Leshno, Y, Lurie, A, Mahomed, N, Mamonova, N, Mendez-Sanchez, J, Mossong, S, Norris, E, Nurmukhametova, M, Oltman, J, Oyunbileg, Ts, Oyunsuren, G, Papatheodoridis, N, Pimenov, M, Prins, P, Puri, S, Radke, A, Rakhmanova, H, Razavi, K, Razavi-Shearer, H W, Reesink, E, Ridruejo, R, Safadi, O, Sagalova, J F, Sanchez Avila, R, Sanduijav, V, Saraswat, I, Schréter, S R, Shah, A, Shevaldin, O, Shibolet, M O, Silva, S, Sokolov, M, Sonderup, K, Souliotis, C W, Spearman, T, Staub, C, Stedman, E A, Strebkova, D, Struck, V, Sypsa, K, Tomasiewicz, L, Undram, A J, van der Meer, D, van Santen, I, Veldhuijzen, F G, Villamil, S, Willemse, E, Zuckerman, F R, Zuure, N, Prabdial-Sing, R, Flisiak, C, Estes

Publikováno v: Journal of Viral Hepatitis, 22, 46-73. Wiley-Blackwell Publishing Ltd
Journal of viral hepatitis, 22(Suppl. 1), 46-73. Wiley-Blackwell
Journal of viral hepatitis, 22, 46-73. Wiley

The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 15 countries, and the relative impact of two scenarios was considered: (i) increased treatment efficacy while holding the treated population constant and (ii) increased treatment ef

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe076bd741e7f950985cd10477176af1
https://pure.eur.nl/en/publications/d704261f-ea94-4ab0-b1f0-d3ed98406f41

Zobrazit plný text záznamu

[Hepatitis C in the Netherlands: sparse data on the current prevalence and the necessity for epidemiological studies and innovative methods for detecting infected individuals]

Autor: A, Kok, F R, Zuure, C J, Weegink, R A, Coutinho, M, Prins

Publikováno v: Nederlands tijdschrift voor geneeskunde. 151(43)

Hepatitis C is a blood-borne virus infection with an estimated 180 million infected individuals worldwide. Hepatitis C virus (HCV) infection may lead to liver failure and cancer of the liver. In 2004, in view of the improved treatment options, the Du

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c900762f2360ab3985c7d653913faa0e
https://pubmed.ncbi.nlm.nih.gov/18232204

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání